Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O9VW
|
||||
| Former ID |
DIB000581
|
||||
| Drug Name |
Lanperisone
|
||||
| Synonyms |
NK-433
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Nervous and musculoskeletal disorders [ICD10:R25-R29] | Phase 3 | [527704] | ||
| Company |
Nippon Kayaku Co Ltd
|
||||
| Formula |
C15H18F3NO
|
||||
| Canonical SMILES |
C(c1ccc(C(=O)[C@@H](CN2CCCC2)C)cc1)(F)(F)F
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium channel protein type 4 subunit alpha | Target Info | Modulator | [527704] | |
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.